Chair , PPM Conference, Philadelphia, April 15th, 2026
Value Based Pricing Guest lecture to Rutgers MBA Pharmacy Students, March 24th, 2026
How do you value Health? Guest lecture to Rutgers MBA Pharmacy Students, April 20th, 2025
Navigating the maze of RWE frameworks from Regulatory and HTA Agencies, 7th Annual Real World Evidence & Life Sciences Analytics Conference, Boston MA, October 17-18, 2024
Improved Decision Making in the Era of Data, Pharma and Biotech Project, Program and Portfolio Management Conference, Boston MA, October 16-18, 2024
How will the US Inflation Reduction Act change pharmaceutical pricing? Podcast recorded June 15th, 2023. Available at https://podcasts.apple.com/gb/podcast/how-will-the-us-inflation-reduction-act-change/id1583167559?i=1000617108236
Paying for Digital Health: What Evidence is Needed? Value and Access Stream Session at Drug Information Association Global Annual Meeting, June 19-23, 2022
Paying for Digital Therapeutics (DTx): What Evidence is Needed? Issue Panel 221 at ISPOR Annual Conference in National Harbor, MD, May 15-18, 2022
Navigate the Global Landscape around RWE, 2nd Real World Evidence & Market Access Symposium, 11-12th April 2022, online
Using Real World Data and Real World Evidence to Improve Portfolio Decisions, 15th Biopharma & Medtech PPM Conference – US East Coast, November 18th – 19th, 2021, online
Step Forward to Step Up, HBA Annual Conference 2021, November 8th-10th, 2021, online
Quo vadis? Results of the Systematic Scoping Review for Digital Health Terms in the Literature, ISPOR Annual Conference, May 17th, 2021, Montreal, Canada
Different Responses to New Therapies on the EU and US Markets, 3rd Annual Pharma Pricing, Reimbursement & Market Access 2020, Dec 2nd – 3rd , 2020, online
Addressing Challenges in EU Market Access and Value Demonstration, Rare Disease Innovation and Partnering Summit, Dec 1st -2nd, 2020 online at https://www.cbinet.com/sites/default/files/brochures/pc20470_brochure.pdf
Real-World Evidence and Reimbursement – Using Data to Guide Innovation and Product Placement, Informa Connect Reimbursement and Access virtual conference, August 25th -27th 2020, online at https://informaconnect.com/reimbursement-access/speakers/
Real-World Data and Demonstrated Value — The Case for Biosimilars and Expensive Therapies, CBI Specialty Therapies and Biosimilars, January 23-25th 2020, Miami, FL, USA
Categorization and Definitions of Digital Health Interventions, ISPOR Digital Health SIG Forum Speaker, ISPOR Europe 2019 Conference, Copenhagen, Denmark, November 2nd – 6th 2019
Building a Value Story using HEOR and RWE, 15th Annual CBI Medical Publications and Communications Forum. September 10th-12th , 2019
Is ICER Influential with Payers? ExL 5th Payer Partnership Forum, Boston MA, June 10th-11th 2019
Do Biosimilars Really Need Real World Evidence?, SMI 5th Biosimilars USA, Iselin NJ, 14th -15th November 2018
Using Real World Evidence to Enhance the Value Proposition, ExL 3rd Payer Partnership Forum, June 11-12th, 2018, Boston, MA, USA
Using Real World Evidence to Drive the Value of the Portfolio, Fleming Project and Portfolio Management, May 22-23, 2018 Philadelphia, PA, USA
XTalks webinar “Real World Evidence: A Data-Centric Approach to Efficiently and Securely Drive Value for the Future of Pharma” March 20th 2018 available at https://xtalks.com/webinars/real-world-evidence-development-with-a-data-centric-approach/
Using Real World Evidence to Enhance the Value Proposition of New Products. ExL New Product Planning, December 7-8th 2017, Boston, MA, USA
Collaborating to bring Value in Development: What can we do in the constraints of RCTs, SMI Pharmaceutical Pricing and Market Access, October 11-12th 2017, London, UK
Integrate Real World Evidence into your Decision-Making Process to Optimize Value, CBI Real World Evidence, September 27-28th 2017, Philadelphia, PA, USA
Collaborating to bring Value in Development: What can we do in the constraints of RCTs? WBRPharmaForce, 18-20th September 2017, Austin, TX, USA
Emerging Pathways for Pricing Assessment Framework, CBI Reimbursement and Access, August 16-17th 2017, Philadelphia, PA, USA
Panel Leader for “How to design (more) patient centric trials including technology: lessons from the Aurora Benchmarking Project”, eyeforpharma Data & Technology in Clinical Trials USA, February 22nd-23rd 2017, Philadelphia, PA. USA
Moderator for Panel Discussion “Build a Robust Value Proposition – Connecting Decisions to Cost-Savings Evidence and Enhanced Patient Outcomes”, CBI Outcomes Based Contracting, October 17th -18th 2016, Philadelphia, PA, USA
Develop Best Practices for Conducting Comparative Effectiveness Research (CER) of Competing Products for Formulary Placement and Rebate Delivery, CBI Outcomes Based Contracting, October 17th-18th 2016, Philadelphia, PA, USA
Moderator for Panel Discussion “Maximize Hub Operation and Field Reimbursement Teams”, CBI Hub and SPP, September 28-29th 2016, San Diego, CA, USA
Understanding and Using the Value Proposition PharmaForce 2016, September 12th -14th 2016, Princeton, NJ, USA
PA, USA
Key Elements and Components for Successful Value-Based Contracting CBI Reimbursement and Access, August 17-18th 2016, Philadelphia, PA, USA
Are Risk Sharing Agreements a good option for formulary management? CBI PBM Formulary Exclusions, March 30-31st 2016, Las Vegas, NV, USA
Engaging Stakeholders using Behavioral Economics, Fleming Europe 11th Annual Sales and Marketing Excellence in Pharma, October 28th -30th 2015, Berlin Germany
Apply Outcomes Studies and Comparative Effectiveness to Demonstrate Value CBI Value Based Pricing and Contracting, October 8th – 9th 2015, Philadelphia, PA, USA
Engaging Stakeholders using Behavioral Economics, PharmaForce 2015, August 25th – 27th 2015, Arlington, VA, USA
PA, USA
Market Access in Europe vs the USA: Myths and Realities, PharmAccess Leaders Forum, June 8th – 10th 2015, Brussels, Belgium
Should Patient Centricity be a Goal for Pharma? Eye for Pharma, Philadelphia Summit April 7th – 8th 2015, Philadelphia
E Adherence: How Wearable Technology is Creating Engaged Patients, American Leaders Pharma Reimbursement and Market Access Strategy Meeting March 24th – 25th, Boston, MA, USA
When is an app just an app? IIR EPharma Summit February 24th – 26th 2015, New York, NY, USA